Tradestie Institutional Equity Comparison Engine

AHCO vs IART โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IART Overall Edge

IART Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Integra LifeSciences Holdings (IART) driven by superior Valuation, Growth & Margin, Momentum & Technical while AHCO counters with relative strength in Options & Structure. Fundamentally, AHCO trades at 7.8x Forward P/E with 3.8% operating margin (+10.9% YoY revenue) versus IART at 5.6x Forward P/E and 9.9% operating margin (+2.3% YoY). In options structure, AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro) against IART sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IART
AHCO 7.8x vs IART 5.6x Fwd P/E
Growth & Margin Winner IART
Op Margin 3.8% vs 9.9% ยท YoY +10.9% vs +2.3%
Momentum & Technical Winner IART
1Y -20.9% vs +18.8% ยท 52W Pos 24% vs 39%
Options & Structure Winner AHCO
SURGE (12th %ile IV) vs BREAKDOWN (16th %ile IV)
AHCO NASDAQ
AdaptHealth Corp. Common Stock
Services-Home Health Care Services
$7.20
-0.69% 1D
Market Cap $989.8M
1M Return +16.69%
1Y Return -20.88%
Forward P/E 7.8x
Unified AI Score
45.2 / 100 HOLD
Tech 29.0 Fund 46.0 Flow 54.0 Mom 60.0
IART NASDAQ
Integra LifeSciences Holdings
Surgical & Medical Instruments & Apparatus
$13.25
-2.21% 1D
Market Cap $1.1B
1M Return +7.51%
1Y Return +18.83%
Forward P/E 5.6x
Unified AI Score
45.5 / 100 HOLD
Tech 43.0 Fund 53.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AHCO -20.88% IART +18.83% Spread: +39.71 pp (IART Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AHCO Revenue IART Revenue AHCO Op. Margin IART Op. Margin Margin Edge
FY2018 $350M $1.47B 9.0% 7.5% AHCO
FY2019 $530M $1.52B 5.5% 6.2% IART
FY2020 $1.06B $1.37B 6.8% 11.0% IART
FY2021 $2.45B $1.54B 9.2% 12.8% IART
FY2022 $2.97B $1.56B 6.4% 15.3% IART
FY2023 $3.20B $1.54B -18.7% 7.2% IART
FY2024 $3.26B $1.61B 8.1% 1.8% AHCO
FY2025 $3.24B $1.64B 2.8% -30.2% AHCO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AHCO (2) vs IART (8)
Institutional Metric AHCO IART Criterion Row Winner
Market Capitalization Scale $989.8M $1.1B Larger Scale IART
Trailing P/E Ratio Valuation 7.8x 79.7x Lower Multiple AHCO
Forward P/E Ratio Valuation 7.8x 5.6x Lower Multiple IART
Revenue Growth (YoY) Growth +10.9% +2.3% Higher Growth AHCO
Operating Margin (TTM) Profitability 3.8% 9.9% Higher Margin IART
Net Profit Margin Profitability -11.8% 0.8% Higher Margin IART
Return on Equity (ROE) Capital Efficiency -28.4% 1.2% Higher ROE IART
52-Week Range Position Momentum 24% ($5โ€“$13) 39% ($9โ€“$20) Stronger Trend IART
Beta / 30D Volatility Risk Regime 0.17ฮฒ ยท 67% Vol 1.54ฮฒ ยท 60% Vol Lower Realized Risk IART
Unified Institutional Score Composite Signal 45.2 / 100 (HOLD) 45.5 / 100 (HOLD) Higher Composite IART

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AHCO vs IART Buy Guide
AHCO SURGE
6d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live AHCO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IART BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live IART Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AHCO nor IART registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.